At a glance
ClinicalIndex Comparison RecordN/ACompleted· 107 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Observational Study to Evaluate the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy
In Brief
An observational study for Arthritis, Psoriatic, Psoriasis. Completed, enrolled 107 participants across 9 sites.
Detailed Summary
The purpose of this study is to conduct an economic analysis on the cost of conventional therapy as compared to biologic therapy and the direct/indirect costs of disease management in patients with refractory psoriatic arthritis (PsA). Primary outcomes are to qualify the economic burden of refractory PsA care. The secondary outcomes are to assess efficacy, safety, and cost effectiveness of different therapies.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsArthritis, Psoriatic, Psoriasis
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2005
First PostedMar 2006
Primary CompletionJun 2011
TodayJul 2026
First PostedMar 15, 2006
Enrollment StartFeb 1, 2005
Primary CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 20.3 years ago